BNN — BRAIN Biotech AG Share News
0.000.00%
Last trade - 00:00- €63.36m
- €63.46m
- €50.22m
CEOs Lukas Linnig And Michael Krohn To Leave Co
Brief: Brain Biotech Signs Exclusive Pharma Licensing Agreement With Akribion For Up To EUR 92.3 Million Milestone Fees Plus Royalties
Brief: BRAIN Biotech 9M Adj. EBITDA at EUR -1.2 Million
Europe Research Roundup: AB Foods, Bunzl, Barratt
Brief: Brain Biotech Says Issuance Of EUR 5 Mln Convertible Bond With Exclusion Of Subscription Rights
Baader Helvea cautiously optimistic on European chemicals, recommends profit taking
Brief: BRAIN Biotech: Bernhard Hauer Leaves Supervisory Board For Personal Reasons
Brief: Brain Biotech Ongoing Q2 Revenues At EUR 13.1 Mln
Brief: BRAIN Biotech Demonstrates Successful Genome Editing Activity In Mammalian Cells
Brief: Brain Q1 Adjusted EBITDA Loss Narrows To EUR 0.3 Mln
Brief: Brain Biotech And Formo: Strategic Partnership For Animal-Free Milk Protein Production
Brief: Brain Group Acquires Majority Of Breatec B.V. And Comix
Brief: BRAIN Biotech FY Revenue Up At EUR 38.4 Mln
Brief: BRAIN Biotech - BRAIN-Engineered-Cas (BEC) Considered Patentable Technology
Brief: BRAIN Biotech Extends Its Genome-Editing Toolbox With Addition Of BRAIN-Metagenome-Cas 01 Nuclease
Brief: BRAIN And SAMS Apply BEC Gene-Editing Technology
Brief: BRAIN Biotech Completes 10% Cash Capital Increase
Brief: BRAIN Biotech To Carry Out Cash Capital Increase
Brief: Brain Biotech Appoints University Of Leiden As Partner For Bec-Enabled Production Strain Development